Cancer Stem Cells: The Potential For Game Change In The Future Of Cancer Drug Development [View article]
Likely. let me find out more. I still dont know the reason (in UK at the moment). The leadership is important but it will likely be better understood as time goes on.
Cancer Stem Cells: The Potential For Game Change In The Future Of Cancer Drug Development [View article]
that's interesting, but many people in leadership are on patents in early phase biotech if they have played a role in the claims of the patent, in fact it is required. The patents must be assigned to an entity however (there is authorship and then ownership of patents which is typically assigned to a company). Steve Jobs was on quite a few patents.
Cancer Stem Cells: The Potential For Game Change In The Future Of Cancer Drug Development [View article]
I should also say that information that will principally move stock will be acquisition (which is a likely case for IMUC) or Phase trial announcements. Exactly when any of this happens, I do not know and neither will others until release. Good question.
Important ASCO Updates On Immunotherapy Drug Treatments [View article]
Interesting thought michelodu. My guess would be that it would not help the immunotherapies because they are already targeted via the already endogenous seek and destroy aspect of the system. i.e. you have an infection in your tonsils or foot, the immune system, if turned against it, will go to the sight and deal with it. However, your approach would be highly applicable to small molecule drugs where toxicity limits the drug. one of the compounds I wrote on here on SA, TH-302 may, would be a good example. the more local concentration you can give, the better assuming you know where to put it (sub mm tumors may escape your view of course).
Important ASCO Updates On Immunotherapy Drug Treatments [View article]
Actually I did not see anything on those two programs in the presentation. there were two presentations and both regarding ICT-107. If I hear anything, I will let you know.
Important Cancer Therapeutics Under Development To Watch [View article]
I think your question is great and I did not look into that. I think it is the case, though with Exelixis as I vaguely remember a study sponsored by a larger partner but dont quote me on that. They had a lot going on in different places.
Cancer Stem Cells: The Potential For Game Change In The Future Of Cancer Drug Development [View article]
Cancer Stem Cells: The Potential For Game Change In The Future Of Cancer Drug Development [View article]
Cancer Stem Cells: The Potential For Game Change In The Future Of Cancer Drug Development [View article]
Cancer Stem Cells: The Potential For Game Change In The Future Of Cancer Drug Development [View article]
Cancer Stem Cells: The Potential For Game Change In The Future Of Cancer Drug Development [View article]
Cancer Stem Cells: The Potential For Game Change In The Future Of Cancer Drug Development [View article]
Important ASCO Updates On Immunotherapy Drug Treatments [View article]
Important ASCO Updates On Immunotherapy Drug Treatments [View article]
Important ASCO Updates On Immunotherapy Drug Treatments [View article]
Important ASCO Updates On Immunotherapy Drug Treatments [View article]
Important ASCO Updates On Immunotherapy Drug Treatments [View article]
Important ASCO Updates On Immunotherapy Drug Treatments [View article]
Discussion With Dr. George E. Peoples About NeuVax (E75) Cancer Vaccine [View article]
Important Cancer Therapeutics Under Development To Watch [View article]
Important Cancer Therapeutics Under Development To Watch [View article]
I would say they were both well received by the clinical community. Hurdles will likely be tox issues but they are innovative and address unmet needs.